BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8977425)

  • 1. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor.
    Li YM; Schacher DH; Liu Q; Arkins S; Rebeiz N; McCusker RH; Dantzer R; Kelley KW
    Endocrinology; 1997 Jan; 138(1):362-8. PubMed ID: 8977425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.
    Furlanetto RW; DiCarlo JN; Wisehart C
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1142-9. PubMed ID: 2952664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protein kinase C-zeta and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I.
    Liu Q; Ning W; Dantzer R; Freund GG; Kelley KW
    J Immunol; 1998 Feb; 160(3):1393-401. PubMed ID: 9570559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
    Neely EK; Rosenfeld RG
    Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
    Angelloz-Nicoud P; Binoux M
    Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
    Thompson MA; Cox AJ; Whitehead RH; Jonas HA
    Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
    Angelloz-Nicoud P; Harel L; Binoux M
    Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes.
    Thomas T; Gori F; Spelsberg TC; Khosla S; Riggs BL; Conover CA
    Endocrinology; 1999 Nov; 140(11):5036-44. PubMed ID: 10537129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells.
    Eicher DJ; Moats-Staats BM; Stiles AD; D'Ercole AJ
    Dev Genet; 1993; 14(3):194-203. PubMed ID: 8358865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins.
    Weber MM; Simmler P; Fottner C; Engelhardt D
    Endocrinology; 1995 Sep; 136(9):3714-20. PubMed ID: 7544271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components.
    Jehle PM; Fussgaenger RD; Blum WF; Angelus NK; Hoeflich A; Wolf E; Jungwirth RJ
    Horm Metab Res; 1999; 31(2-3):97-102. PubMed ID: 10226788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells.
    Grant ES; Ross MB; Ballard S; Naylor A; Habib FK
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3252-7. PubMed ID: 9745438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
    Berlato C; Doppler W
    Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.